01948oam 2200433Ia 450 991069873720332120091223162307.0(CKB)5470000002396485(OCoLC)318814007(EXLCZ)99547000000239648520090420d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierQ4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions[electronic resource] annex 5, disintegration test general chapter[Silver Spring, MD] :[Center for Drug Evaluation and Research] ;[Rockville, MD]:[U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research],[2008]5 unnumbered pages digital, PDF fileTitle from PDF title page (viewed on Apr. 20, 2009)."International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"--p. [2]."Draft consensus guideline.""Current step 2 version, dated June 5, 2008."Includes bibliographical references (page [4]).Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions Tablets (Medicine)TestingCapsules (Pharmacy)TestingTablets (Medicine)Testing.Capsules (Pharmacy)Testing.Center for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)International Conference on Harmonisation.GPOGPOGPOBOOK9910698737203321Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions3471792UNINA